212 related articles for article (PubMed ID: 1287674)
1. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.
Hamel E
Pharmacol Ther; 1992; 55(1):31-51. PubMed ID: 1287674
[TBL] [Abstract][Full Text] [Related]
2. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. Inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain.
Bai R; Pettit GR; Hamel E
Biochem Pharmacol; 1990 Jun; 39(12):1941-9. PubMed ID: 2353935
[TBL] [Abstract][Full Text] [Related]
3. Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data.
Bai RL; Paull KD; Herald CL; Malspeis L; Pettit GR; Hamel E
J Biol Chem; 1991 Aug; 266(24):15882-9. PubMed ID: 1874739
[TBL] [Abstract][Full Text] [Related]
4. Binding of dolastatin 10 to tubulin at a distinct site for peptide antimitotic agents near the exchangeable nucleotide and vinca alkaloid sites.
Bai RL; Pettit GR; Hamel E
J Biol Chem; 1990 Oct; 265(28):17141-9. PubMed ID: 2211617
[TBL] [Abstract][Full Text] [Related]
5. The spongistatins, potently cytotoxic inhibitors of tubulin polymerization, bind in a distinct region of the vinca domain.
Bai R; Taylor GF; Cichacz ZA; Herald CL; Kepler JA; Pettit GR; Hamel E
Biochemistry; 1995 Aug; 34(30):9714-21. PubMed ID: 7626642
[TBL] [Abstract][Full Text] [Related]
6. Spongistatin 1, a highly cytotoxic, sponge-derived, marine natural product that inhibits mitosis, microtubule assembly, and the binding of vinblastine to tubulin.
Bai R; Cichacz ZA; Herald CL; Pettit GR; Hamel E
Mol Pharmacol; 1993 Oct; 44(4):757-66. PubMed ID: 8232226
[TBL] [Abstract][Full Text] [Related]
7. Interaction of ustiloxin A with bovine brain tubulin.
Ludueńa RF; Roach MC; Prasad V; Banerjee M; Koiso Y; Li Y; Iwasaki S
Biochem Pharmacol; 1994 Apr; 47(9):1593-9. PubMed ID: 8185673
[TBL] [Abstract][Full Text] [Related]
8. Interaction of rhizoxin with bovine brain tubulin.
Sullivan AS; Prasad V; Roach MC; Takahashi M; Iwasaki S; Ludueña RF
Cancer Res; 1990 Jul; 50(14):4277-80. PubMed ID: 2364385
[TBL] [Abstract][Full Text] [Related]
9. Tubulin as a target for anticancer drugs: agents which interact with the mitotic spindle.
Jordan A; Hadfield JA; Lawrence NJ; McGown AT
Med Res Rev; 1998 Jul; 18(4):259-96. PubMed ID: 9664292
[TBL] [Abstract][Full Text] [Related]
10. Interaction of marine toxin dolastatin 10 with porcine brain tubulin: competitive inhibition of rhizoxin and phomopsin A binding.
Li Y; Kobayashi H; Hashimoto Y; Shirai R; Hirata A; Hayashi K; Hamada Y; Shioiri T; Iwasaki S
Chem Biol Interact; 1994 Dec; 93(3):175-83. PubMed ID: 7923438
[TBL] [Abstract][Full Text] [Related]
11. Interaction of halichondrin B and homohalichondrin B with bovine brain tubulin.
Ludueña RF; Roach MC; Prasad V; Pettit GR
Biochem Pharmacol; 1993 Jan; 45(2):421-7. PubMed ID: 8435093
[TBL] [Abstract][Full Text] [Related]
12. Interaction of phomopsin A with porcine brain tubulin. Inhibition of tubulin polymerization and binding at a rhizoxin binding site.
Li Y; Kobayashi H; Tokiwa Y; Hashimoto Y; Iwasaki S
Biochem Pharmacol; 1992 Jan; 43(2):219-24. PubMed ID: 1739410
[TBL] [Abstract][Full Text] [Related]
13. Dolastatin 15 binds in the vinca domain of tubulin as demonstrated by Hummel-Dreyer chromatography.
Cruz-Monserrate Z; Mullaney JT; Harran PG; Pettit GR; Hamel E
Eur J Biochem; 2003 Sep; 270(18):3822-8. PubMed ID: 12950266
[TBL] [Abstract][Full Text] [Related]
14. Cryptophycin 1 binds to tubulin at a site distinct from the colchicine binding site and at a site that may overlap the vinca binding site.
Mooberry SL; Taoka CR; Busquets L
Cancer Lett; 1996 Oct; 107(1):53-7. PubMed ID: 8913266
[TBL] [Abstract][Full Text] [Related]
15. Effects of antimitotic agents on tubulin-nucleotide interactions.
Correia JJ
Pharmacol Ther; 1991 Nov; 52(2):127-47. PubMed ID: 1818332
[TBL] [Abstract][Full Text] [Related]
16. Antimicrotubular drugs binding to vinca domain of tubulin.
Gupta S; Bhattacharyya B
Mol Cell Biochem; 2003 Nov; 253(1-2):41-7. PubMed ID: 14619954
[TBL] [Abstract][Full Text] [Related]
17. Vinca site agents induce structural changes in tubulin different from and antagonistic to changes induced by colchicine site agents.
Sackett DL
Biochemistry; 1995 May; 34(21):7010-9. PubMed ID: 7766610
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10.
Edler MC; Fernandez AM; Lassota P; Ireland CM; Barrows LR
Biochem Pharmacol; 2002 Feb; 63(4):707-15. PubMed ID: 11992639
[TBL] [Abstract][Full Text] [Related]
19. Interaction of dolastatin 10 with bovine brain tubulin.
Ludueña RF; Roach MC; Prasad V; Pettit GR
Biochem Pharmacol; 1992 Feb; 43(3):539-43. PubMed ID: 1540211
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of vinca alkaloids and phomopsin hybrids.
Ngo QA; Roussi F; Cormier A; Thoret S; Knossow M; Guénard D; Guéritte F
J Med Chem; 2009 Jan; 52(1):134-42. PubMed ID: 19072542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
